Loading...
XHKG
0460
Market cap812mUSD
Oct 09, Last price  
0.74HKD
1D
4.96%
1Q
-12.94%
Jan 2017
-65.74%
IPO
-73.76%
Name

Sihuan Pharmaceutical Holdings Group Ltd

Chart & performance

D1W1MN
XHKG:0460 chart
P/E
31.71
P/S
2.18
EPS
0.02
Div yield, %
1.55%
Shrs. gr., 5y
-0.73%
Rev. gr., 5y
1.22%
Revenues
2.62b
+37.71%
161,776,000286,349,000510,048,000708,907,0001,036,881,0002,242,063,0003,042,531,0004,732,700,0003,084,236,0003,167,211,0003,185,699,0002,745,809,0002,917,405,0002,878,318,0002,464,226,0003,038,391,0002,181,189,0001,860,539,0001,901,109,0002,618,008,000
Net income
180m
P
90,453,000179,266,000237,059,000326,316,000522,065,000824,048,000904,402,0001,303,012,0001,671,281,0002,062,378,0001,708,239,0001,448,935,0001,619,956,000-2,753,332,000473,382,000416,509,000-1,914,918,000-54,017,000-216,662,000179,696,000
CFO
-24m
L
75,980,000182,263,000261,169,000385,648,000380,101,000712,934,0001,046,064,0001,510,633,0001,760,936,0001,568,610,0002,018,026,0001,917,590,0001,792,794,0001,417,858,000227,131,000665,293,00046,493,000199,487,000243,887,000-23,561,000
Dividend
Jun 30, 20260.0109 HKD/sh

Notes

No notes on this company yet
Write a private note on this company, for your eyes only
Add note

Profile

Sihuan Pharmaceutical Holdings Group Ltd. engages in the research and development, manufacture, and sale of pharmaceutical products. It operates through the following segments: Medical Aesthetic Products, Innovative Medicine and Other Medicine, and Generic Medicine. The Medical Aesthetic Products refers to the filling, shaping, supporting, supplementing, optoelectronic device, body sculpturing, skin care and others to provide non- or minimally invasive medical aesthetics comprehensive solutions. The company was founded by Feng Sheng Che and Wei Cheng Guo in 2001 and is headquartered in Beijing, China.

Key people

Fengsheng Che
Executive Chairman of the Board · since 2014
Guili Miao
Deputy Chief Executive Officer, Chief Financial Officer, Executive Director · since 2022
Yanling Chen
Executive Director, Joint Company Secretary · since 2022
Weicheng Guo
Executive Deputy Chairman of the Board, Chief Executive Officer · since 2014
Jionglong Zhang
Executive Director · since 2021
Kin Wai Li
Joint Company Secretary · since 2022
Wah Kwong Tsang
Non-Executive Independent Director · since 2013
Guan Wang
Non-Executive Independent Director · since 2023
Xun Zhu
Non-Executive Independent Director · since 2014
URL
http://www.sihuanpharm.com/
IPO date
Oct 28, 2010
Employees
3,241
Domiciled in
CN
Incorporated in
BM
Legal address
c/o „Conyers Corporate Services (Bermuda) Limited“, Clarendon House, 2 Church Street
Hamilton HM 11
BM
Headquarters
Room 4905, Office Tower, Convention Plaza, 1 Harbour Road, Wanchai
Hong Kong
HK

Valuation

Title
CNY in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2025‑122024‑122023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑12
Income
Revenues
Cost of revenue
Unusual Expense (Income)
NOPBT
NOPBT Margin
Operating Taxes
Tax Rate
NOPAT
Net income
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
Cash flow
Cash from operating activities
CAPEX
Cash from investing activities
Cash from financing activities
FCF
Balance
Cash
Long term investments
Excess cash
Stockholders' equity
Invested Capital
ROIC
ROCE
EV
Common stock shares outstanding
Price
Market cap
EV
EBITDA
EV/EBITDA
Interest
Interest/NOPBT